MaxCyte, Inc.

MXCT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12,416-$12,357-$10,261-$10,597
Dep. & Amort.$1,072$1,276$1,277$1,057
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$1,894-$1,786-$7,694-$1,711
Other Non-Cash$1,992$3,015$2,267$3,430
Operating Cash Flow-$7,458-$9,852-$14,411-$7,821
Investing Activities
PP&E Inv.-$300-$584-$653-$147
Net Acquisitions$0$0-$1,773$0
Inv. Purchases-$34,508-$28,878-$34,645-$32,518
Inv. Sales/Matur.$40,000$31,000$46,600$31,000
Other Inv. Act.$0$0$0$0
Investing Cash Flow$5,192$1,538$9,529-$1,665
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$14$154$383$412
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$14$154$383$412
Forex Effect$0$0$0$0
Net Chg. in Cash-$2,252-$8,160-$4,499-$9,074
Supplemental Information
Beg. Cash$15,225$23,385$27,884$36,958
End Cash$12,973$15,225$23,385$27,884
Free Cash Flow-$7,758-$10,436-$15,064-$7,968
MaxCyte, Inc. (MXCT) Financial Statements & Key Stats | AlphaPilot